OxyMem offers ‘drop-in’ Membrane Aerated Biofilm Reactor (MABR) modules to complement existing treatment systems and deliver up to 50% additional biological capacity. Its patented, bubble-less transfer of oxygen enables simultaneous nitrification and denitrification for total nitrogen removal, energy savings up to 75%, reduces sludge by up to 50% without the need of additional infrastructure. The company’s Integrated Fixed-film Activated Sludge design (IFAS) allows facilities to achieve incremental expansion of existing industrial and municipal activated sludge systems. Acquired by DuPont in 2019, OxyMem was the first company to commercialize MABR technology.

Request an invitation